---
figid: PMC9247951__10555_2022_10048_Fig2_HTML
figtitle: Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance
organisms:
- NA
pmcid: PMC9247951
filename: 10555_2022_10048_Fig2_HTML.jpg
figlink: /pmc/articles/PMC9247951/figure/Fig2/
number: F2
caption: Schematic representation of NRP2 expression regulation and downstream signaling.
  a NRP2 expression regulation. The factors regulating the NRP2 expression in physiological
  and pathological conditions are depicted here. In physiological condition forskolin
  suppresses, while Prox1, GATA2, and Paxillin upregulates its levels. In cancer,
  TGFβ upregulates, while Wnt antagonist, Pax8, miRNAs, DLX2 decreases its expression.
  In ischemia, its levels are found to be elevated where HIF could play a role. b
  Proposed schematic diagram of NRP2 signaling pathway. NRP2 interacts with different
  ligand molecules and mediates the downstream signaling cascade. They are necessary
  for the semaphorin/plexin mediated signaling, while they act as co-receptors for
  VEGFR, c-Met, PDGFR, FGFR, Integrins, and TGFβ to enhance their signaling. I It
  interacts with semaphorin and Plexin to regulate axon guidance cues, synaptic transmission,
  and inhibit tumor progression. II It interacts with the VEGF and promotes angiogenesis,
  lymphangiogenesis, vasculogenesis and activates ERK/PI3K/p38/Src to promote tumor
  progression. III It interacts with c-Met/PDGFR/FGFR and promotes tumor progression
  via ERK/PI3K/p38/Src mechanism. IV It interacts with integrin and via FAK-Ras/MEK-Gli1
  pathway to promote tumor progression. V It interacts with TGFβ to promote EMT via
  SPP1/OPN/Osteopontin and promotes tumor progression via activated Smad signaling.
  The orange boxes indicate their physiological function and gray boxes indicate their
  cancer-specific function
papertitle: Role of Neuropilin-2-mediated signaling axis in cancer progression and
  therapy resistance.
reftext: Ridwan Islam, et al. Cancer Metastasis Rev. 2022 Jul 1 ;41(3):771-787.
year: '2022'
doi: 10.1007/s10555-022-10048-0
journal_title: Cancer Metastasis Reviews
journal_nlm_ta: Cancer Metastasis Rev
publisher_name: Springer US
keywords: Neuropilin-2 | NRP2 | Cancer | Tumorigenesis | Signaling
automl_pathway: 0.9044194
figid_alias: PMC9247951__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9247951__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9247951__10555_2022_10048_Fig2_HTML.html
  '@type': Dataset
  description: Schematic representation of NRP2 expression regulation and downstream
    signaling. a NRP2 expression regulation. The factors regulating the NRP2 expression
    in physiological and pathological conditions are depicted here. In physiological
    condition forskolin suppresses, while Prox1, GATA2, and Paxillin upregulates its
    levels. In cancer, TGFβ upregulates, while Wnt antagonist, Pax8, miRNAs, DLX2
    decreases its expression. In ischemia, its levels are found to be elevated where
    HIF could play a role. b Proposed schematic diagram of NRP2 signaling pathway.
    NRP2 interacts with different ligand molecules and mediates the downstream signaling
    cascade. They are necessary for the semaphorin/plexin mediated signaling, while
    they act as co-receptors for VEGFR, c-Met, PDGFR, FGFR, Integrins, and TGFβ to
    enhance their signaling. I It interacts with semaphorin and Plexin to regulate
    axon guidance cues, synaptic transmission, and inhibit tumor progression. II It
    interacts with the VEGF and promotes angiogenesis, lymphangiogenesis, vasculogenesis
    and activates ERK/PI3K/p38/Src to promote tumor progression. III It interacts
    with c-Met/PDGFR/FGFR and promotes tumor progression via ERK/PI3K/p38/Src mechanism.
    IV It interacts with integrin and via FAK-Ras/MEK-Gli1 pathway to promote tumor
    progression. V It interacts with TGFβ to promote EMT via SPP1/OPN/Osteopontin
    and promotes tumor progression via activated Smad signaling. The orange boxes
    indicate their physiological function and gray boxes indicate their cancer-specific
    function
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NRP2
  - NELL2
  - GATA2
  - PROX1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - KDR
  - FLT1
  - FLT4
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - PODN
  - PODNL1
  - HGF
  - IL6
  - SOS1
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - TGFB1
  - TGFB2
  - TGFB3
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - SRC
  - FGR
  - FYN
  - YES1
  - EPHB2
  - MAPK3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MET
  - PDGFRB
  - PDGFRA
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - WIF1
  - PAX8
  - DLX2
  - PTK2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - KRAS
  - HRAS
  - NRAS
  - GLI1
  - SMAD7
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD9
  - SMAD2
  - SMAD3
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - ITK
  - SLC22A3
  - SPP1
  - CXXC1
  - SGPP1
---
